| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
32,033 |
25,122 |
$2.30M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,710 |
5,401 |
$360K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
713 |
500 |
$48K |
| 99051 |
|
3,624 |
2,985 |
$38K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,805 |
2,287 |
$12K |
| 99050 |
|
1,207 |
1,116 |
$8K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
63 |
54 |
$5K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
42 |
41 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
13 |
13 |
$1K |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
149 |
141 |
$136.73 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,116 |
912 |
$31.76 |
| 81002 |
|
873 |
654 |
$3.14 |
| 90656 |
|
35 |
33 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
413 |
306 |
$0.00 |
| 1000F |
|
1,315 |
1,083 |
$0.00 |
| 2001F |
|
1,448 |
1,192 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
577 |
536 |
$0.00 |
| 2010F |
|
1,381 |
1,154 |
$0.00 |
| 3074F |
|
983 |
819 |
$0.00 |
| 3008F |
|
1,546 |
1,283 |
$0.00 |
| 3079F |
|
202 |
170 |
$0.00 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
55 |
53 |
$0.00 |
| 97802 |
|
102 |
101 |
$0.00 |
| 92551 |
|
129 |
126 |
$0.00 |
| 1036F |
|
498 |
417 |
$0.00 |
| 90686 |
|
116 |
108 |
$0.00 |
| 90688 |
|
87 |
78 |
$0.00 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
50 |
40 |
$0.00 |
| 1034F |
|
111 |
83 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
21 |
21 |
$0.00 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
118 |
102 |
$0.00 |
| 3075F |
|
13 |
12 |
$0.00 |
| 99173 |
|
121 |
119 |
$0.00 |
| 90715 |
|
29 |
29 |
$0.00 |
| 1159F |
|
1,193 |
938 |
$0.00 |
| 1033F |
|
396 |
315 |
$0.00 |
| 98960 |
|
130 |
128 |
$0.00 |
| 81025 |
|
19 |
13 |
$0.00 |
| 3078F |
|
884 |
741 |
$0.00 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
57 |
55 |
$0.00 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
383 |
257 |
$0.00 |
| 90756 |
|
14 |
14 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
22 |
21 |
$0.00 |
| 3077F |
|
47 |
41 |
$0.00 |